Iconiq Capital, LLC Kodiak Sciences Inc. Transaction History
Iconiq Capital, LLC
- $4.6 Billion
- Q3 2024
A detailed history of Iconiq Capital, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Iconiq Capital, LLC holds 1,016,864 shares of KOD stock, worth $5.62 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,016,864
Previous 1,016,864
-0.0%
Holding current value
$5.62 Million
Previous $2.39 Million
11.09%
% of portfolio
0.06%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding KOD
# of Institutions
97Shares Held
39MCall Options Held
6.5KPut Options Held
5.8K-
Baker Bros. Advisors LP New York, NY17.3MShares$95.7 Million0.48% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$21.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$10.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$9.32 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.01MShares$5.58 Million0.34% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $288M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...